Hysterectomy

References

Citations

1. Gimbel H, et al. (2005). Lower urinary tract symptoms after total and subtotal hysterectomy: Results of a randomized controlled trial. International Urogynecology Journal, 16: 257–262.

2. Thakar RT, et al. (2002). Outcomes after total versus subtotal abdominal hysterectomy. New England Journal of Medicine, 347(17): 1318–1325.

3. American College of Obstetricians and Gynecologists (2007). Supracervical hysterectomy. ACOG Committee Opinion No. 388. Obstetrics and Gynecology, 110(5): 1215–1217.

4. Benassi L, et al. (2002). Abdominal or vaginal hysterectomy for enlarged uteri: A randomized clinical trial. American Journal of Obstetrics and Gynecology, 187: 1561–1565.

5. Campbell ES, et al. (2003). Types of hysterectomy: Comparison of characteristics, hospital costs, utilization and outcomes. Journal of Reproductive Medicine, 48: 943–949.

6. Garry R, et al. (2004). The eVALuate study: Two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ, 328(7432): 129.

7. Hoffman CP, et al. (2005). Laparoscopic hysterectomy: The Kaiser Permanente San Diego experience. Journal of Minimally Invasive Gynecology, 12(1): 16–24.

8. Ghezzi F, et al. (2006). Laparoscopic-assisted vaginal hysterectomy versus total laparoscopic hysterectomy for the management of endometrial cancer: A randomized clinical trial. Journal of Minimally Invasive Gynecology, 13(2): 114–120.

9. Abramowicz M (2004). Antimicrobial prophylaxis for surgery. Treatment Guidelines From the Medical Letter, 2(20): 27–32.

10. Farquhar CM, Steiner CA (2002). Hysterectomy rates in the United States 1900–1997. Obstetrics and Gynecology, 99(2): 229–234.

11. Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA, 291(14): 1701–1712.

12. North American Menopause Society (2004). Abridged recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of the North American Menopause Society. Menopause Management, 13(6): 12–19. Also available online: http://www.menopausemgmt.com/issues/13-06/issue.html.

13. Rossouw JE, et al. (2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA, 297(13): 1465–1477.

14. Beral V, et al. (2007). Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet, 369(9574): 1703–1710.

15. American College of Obstetricians and Gynecologists Women's Health Care Physicians (2004). Breast cancer. Obstetrics and Gynecology, 104(4, Suppl): 11S–16S.

16. Million Women Study Collaborators (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362(9382): 419–427.

17. American College of Obstetricians and Gynecologists Women's Health Care Physicians (2004). Stroke. Obstetrics and Gynecology, 104(4, Suppl): 97S–105S.

Go to previous section	Go to top of page	Go to next section
Author:	Sandy Jocoy, RN	Last Updated: August 12, 2008
Medical Review:	Sarah Marshall, MD - Family Medicine Kirtly Jones, MD - Obstetrics and Gynecology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.